Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1014 of 1,261

  1. US 7645881

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  2. US 7645441

    Compositions and methods in cancer associated with altered expression of PRLR

    Sagres Discovery, Inc. · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  3. US 7645732

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  4. US 7645789

    Indole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  5. US 7641906

    Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  6. US 7642234

    Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  7. US 7642275

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  8. US 7641909

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  9. US 7641902

    Compositions and methods for detecting cancer and for inhibiting metastasis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  10. US 7642253

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  11. US 7642280

    Inhibitors of acyl glucosaminyl inositol amidase and methods of use

    The Regents of the University of California · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  12. US 7642355

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  13. US 2009326434

    Anti-Microbial Photodynamic Therapy

    NIFANTIEV NIKOLAY E [RU] · Granted Dec 31, 2009 · Expires Dec 26, 2029

    granted

  14. US 7638333

    Anthrax vaccine

    The United States of America as represented by the Secretary of the Army · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  15. US 7638282

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  16. US 7638550

    Pyrrolic derivatives with histone deacetylase inhibitory activity

    Universidad del Pais Vasco-Euskal Herriko Unibertsitatea (UPV-EHU) Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (CNIO) · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  17. US 7638134

    Insertion sites in fowlpox vectors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  18. US 7638145

    Cultivated agarwood

    Regents of the University of Minnesota · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  19. US 7638543

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  20. US 7638283

    Amyloid β protein (globular assembly and uses thereof)

    Northwestern University · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  21. US 7638284

    Immunoglobulin A inducing protein and uses therefor

    The Board of Regents of the University of Texas · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  22. US 7638269

    Viral capsid assembly intermediates and methods of production

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  23. US 7638300

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  24. US 7638135

    Collagen-binding proteins from enterococcal bacteria

    The Board of Regents of the University of Texas System · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.